Literature DB >> 25370281

Depression and anxiety.

John W G Tiller1.   

Abstract

Comorbid depression and anxiety disorders occur in up to 25% of general practice patients. About 85% of patients with depression have significant anxiety, and 90% of patients with anxiety disorder have depression. Symptomatology may initially seem vague and non-specific. A careful history and examination with relevant investigations should be used to make the diagnosis. Once the diagnosis is made, rating scales may identify illness severity and help in monitoring treatment progress. Both the depression disorder and the specific anxiety disorder require appropriate treatment. Psychological therapies, such as cognitive behaviour therapy, and antidepressants, occasionally augmented with antipsychotics, have proven benefit for treating both depression and anxiety. Benzodiazepines may help alleviate insomnia and anxiety but not depression. They have dependency and withdrawal issues for some people, and may increase the risk of falls in older people. Despite the availability of treatments, 40% of patients with depression or anxiety do not seek treatment, and of those who do, less than half are offered beneficial treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 25370281     DOI: 10.5694/mja12.10628

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  60 in total

1.  Bidirectional Regulation of Cognitive and Anxiety-like Behaviors by Dentate Gyrus Mossy Cells in Male and Female Mice.

Authors:  Justin J Botterill; K Yaragudri Vinod; Kathleen J Gerencer; Cátia M Teixeira; John J LaFrancois; Helen E Scharfman
Journal:  J Neurosci       Date:  2021-01-20       Impact factor: 6.167

2.  The impact of comorbid spinal pain in depression on work participation and clinical remission following brief or short psychotherapy. Secondary analysis of a randomized controlled trial with two-year follow-up.

Authors:  Marjon E A Wormgoor; Aage Indahl; Jens Egeland
Journal:  PLoS One       Date:  2022-08-22       Impact factor: 3.752

3.  Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders.

Authors:  Parvin Oroojzadeh; Saber Yari Bostanabad; Hajie Lotfi
Journal:  J Mol Neurosci       Date:  2022-07-18       Impact factor: 2.866

4.  Effectiveness of behavioral activation for depression treatment in medical students: Study protocol for a quasi-experimental design.

Authors:  Alejandro Domínguez Rodríguez; Gustavo Iván Martinez-Maqueda; Paulina Arenas Landgrave; Sofía Cristina Martínez Luna; Flor Rocío Ramírez-Martínez; Jasshel Teresa Salinas Saldivar
Journal:  SAGE Open Med       Date:  2020-07-27

5.  The Association Between Dietary Zinc Intake and Health Status, Including Mental Health and Sleep Quality, Among Iranian Female Students.

Authors:  Hossein Hajianfar; Negar Mollaghasemi; Rahele Tavakoly; Marilyn S Campbell; Mohadese Mohtashamrad; Arman Arab
Journal:  Biol Trace Elem Res       Date:  2020-08-02       Impact factor: 3.738

6.  Ciliary neurotrophic factor is a key sex-specific regulator of depressive-like behavior in mice.

Authors:  Cuihong Jia; Russell W Brown; Hannah M Malone; Katherine C Burgess; W Drew Gill; Matthew P Keasey; Theo Hagg
Journal:  Psychoneuroendocrinology       Date:  2018-09-29       Impact factor: 4.905

7.  The association of depression and diabetes across methods, measures, and study contexts.

Authors:  Jaimie C Hunter; Brenda M DeVellis; Joanne M Jordan; M Sue Kirkman; Laura A Linnan; Christine Rini; Edwin B Fisher
Journal:  Clin Diabetes Endocrinol       Date:  2018-01-04

Review 8.  Reviewing the Effectiveness of Music Interventions in Treating Depression.

Authors:  Daniel Leubner; Thilo Hinterberger
Journal:  Front Psychol       Date:  2017-07-07

Review 9.  Mental Health Smartphone Apps: Review and Evidence-Based Recommendations for Future Developments.

Authors:  David Bakker; Nikolaos Kazantzis; Debra Rickwood; Nikki Rickard
Journal:  JMIR Ment Health       Date:  2016-03-01

Review 10.  Cultural aspects of anxiety disorders in India.

Authors:  Maherra Khambaty; Rajesh M Parikh
Journal:  Dialogues Clin Neurosci       Date:  2017-06       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.